Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Antidilutive Securities (Details)

v3.20.2
Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 4,848,044 11,445,443 12,691,701 11,445,443
Options to purchase common stock        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 1,394,009 556,252 1,394,009
Unvested RSUs and PSUs        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 1,787,608 1,766,715 1,787,608
Warrants        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 470,000 470,000 470,000
Convertible Notes        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 4,848,044 7,793,826 9,898,734 7,793,826